Ketogenic Diet Disrupts the Circadian Clock and Increases Hypofibrinolytic Risk by Inducing Expression of Plasminogen Activator Inhibitor-1
Authors:
- Katsutaka OishiKOKatsutaka Oishi
- Daisuke UchidaDUDaisuke Uchida
- Naoki OhkuraNONaoki Ohkura
- Ryosuke DoiRDRyosuke Doi
- Norio IshidaNINorio Ishida
- Koji KadotaKKKoji Kadota
- Shuichi HorieSHShuichi Horie
- 1 October 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 29 (10) , 1571-1577
Abstract
Objectives— Metabolic disorders such as diabetes and obesity are considered risk factors for cardiovascular diseases by increasing levels of blood plasminogen activator inhibitor-1 (PAI-1). Ketogenic diets (KDs) have been used as an approach to weight loss in both obese and nonobese individuals. We examined circadian changes in plasma PAI-1 and its mRNA expression levels in tissues from mice fed with a KD (KD mice), to evaluate its effects on fibrinolytic functions. Methods and Results— Two weeks on the kDa increased plasma levels of free fatty acids and ketones accompanied by hypoglycemia in mice. Plasma PAI-1 concentrations were extremely elevated in accordance with mRNA expression levels in the heart and liver, but not in the kidneys of KD mice. Circadian expression of PAI-1 mRNA was phase-advanced for 4.7, 7.9, and 7.8 hours in the heart, kidney, and adipose tissues, respectively, as well as that of circadian genes mPer2 and DBP in KD mice, suggesting that peripheral clocks were phase-advanced by ketosis despite feeding ad libitum under a periodic light-dark cycle. The circadian clock that regulates behavioral activity rhythms was also phase-advanced, and its free-running period was significantly shortened in KD mice. Conclusions— Our findings suggest that ketogenic status increases hypofibrinolytic risk by inducing abnormal circadian expression of PAI-1.Keywords
This publication has 49 references indexed in Scilit:
- Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: Lessons from the liverThrombosis and Haemostasis, 2008
- Transcriptional regulation of the plasminogen activator inhibitor type 1 – with an emphasis on negative regulationThrombosis and Haemostasis, 2008
- Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis preventionAdvanced Drug Delivery Reviews, 2007
- Circadian Variation in Stroke Onset: Identical Temporal Pattern in Ischemic and Hemorrhagic EventsChronobiology International, 2005
- Circadian Variation in the Onset of Myocardial InfarctionDiabetes, 2003
- Circadian rhythm in the cardiovascular system: chronocardiologyAmerican Heart Journal, 2003
- Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2Journal of Molecular and Cellular Cardiology, 2003
- Coordination of circadian timing in mammalsNature, 2002
- Molecular Analysis of Mammalian Circadian RhythmsAnnual Review of Physiology, 2001
- CLIF, a Novel Cycle-like Factor, Regulates the Circadian Oscillation of Plasminogen Activator Inhibitor-1 Gene ExpressionJournal of Biological Chemistry, 2000